Video

ESC 22 Late-breaker Discussion: The DELIVER Trial

Published: 24 Aug 2022

  • Views:

    Views Icon 216
  • Likes:

    Heart Icon 1

ESC Congress 22 — Dr Harriette Van Spall (McMaster University, CA) sits down with PI, Dr Scott D Solomon (Brigham & Women's Hospital & Harvard Medical School, US) to discuss one of the most awaited trials of 2022, DELIVER (NCT03619213). 

This study assessed the effect of dapagliflozin 10 mg versus placebo, given once daily in addition to background regional standard of care therapy, including treatments to control co-morbidities, in reducing the composite of CV death or heart failure events.